One journal found when searched for:
||Molecular Cancer Therapeutics (ISSN: 1535-7163, ESSN: 1538-8514)
||This is a RoMEO yellow journal|
||A paid open access option is available for this journal.
|| author can archive pre-print (ie pre-refereeing)|
|| subject to Restrictions below, author can archive post-print (ie final draft post-refereeing)|
|| author cannot archive publisher's version/PDF|
- Author's pre-print on institutional website or pre-print server, such as bioRxiv
- Authors final version may be deposited on institutional website or institutional repository only, if required by institution
- Published source must be acknowledged
- Must link to the publisher PDF of article on journal website
- NIH authors may post authors' own version in PubMed Central for release 12 months after publication or have it deposited on their behalf by the publisher
- HHMI, Wellcome Trust, Cancer Research UK and UK Medical Research Council authors may deposit authors own version in Europe PMC for release 6 months after publication or have it deposited on their behalf by the publisher
||Compliance data is available for 14 funders|
|Paid Open Access:
- Publisher last reviewed on 06/12/2016
||Pre-print policy - Copyright, Permissions and Access|
||23-Jun-2017 - Suggest an update for this record|
|Link to this page:
This summary is for the journal's default policies, and changes or exceptions can often be negotiated by authors.
All information is correct to the best of our knowledge but should not be relied upon for legal advice.
|Use this site to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.|
The RoMEO Journals database is supplemented with information kindly provided by:
- the Zetoc service, funded by Jisc with data provided by the British Library,
- the Directory of Open Access Journals (DOAJ) managed by Infrastructure Services for Open Access,
- the Entrez journal list hosted by the NCBI.